Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled trial of Xinlikang capsules for cancer-related fatigue in colorectal cancer patients
CTR20261655Phase 2Active
- Sponsor
- Guiyang Xintian Pharmaceutical Co., Ltd.
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of enalapril in cancer-related fatigue (CRF), sponsored by Guiyang Xintian Pharmaceutical Co., Ltd.. Started Jul 2026; status: active.
02
Drugs
enalapril
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on CTR20261655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261655.